"Scientists have identified two non intoxicating compounds from cannabis that may help reduce liver fat while improving metabolic health. The compounds, CBD and CBG, appear to support the liver in two important ways. They increase the organ's ability to store backup energy and restore the activity of cellular systems that break down harmful waste."
"Their study suggests that Cannabidiol (CBD) and Cannabigerol (CBG), which do not cause a high, may improve liver health by altering how liver cells handle energy and remove unwanted material. Together, these effects could offer a new plant based strategy for treating the most common chronic liver disorder worldwide."
"Metabolic dysfunction associated steatotic liver disease (MASLD) is currently the most widespread chronic liver condition in the world. It affects roughly one third of adults and is strongly associated with obesity, high blood pressure, and insulin resistance."
CBD and CBG are non-intoxicating cannabis compounds that may combat fatty liver disease, which affects approximately one-third of adults worldwide. These compounds work by increasing the liver's ability to store backup energy and restoring cellular systems responsible for breaking down harmful waste. Research from the Hebrew University of Jerusalem demonstrates that both CBD and CBG improve blood sugar control and reduce harmful lipids associated with fatty liver disease. This plant-based approach offers a promising new treatment strategy for metabolic dysfunction associated steatotic liver disease (MASLD), the most common chronic liver disorder globally, which is strongly linked to obesity, high blood pressure, and insulin resistance.
Read at ScienceDaily
Unable to calculate read time
Collection
[
|
...
]